1.87
price up icon5.65%   0.10
after-market Dopo l'orario di chiusura: 1.87
loading
Precedente Chiudi:
$1.77
Aprire:
$1.86
Volume 24 ore:
119.10K
Relative Volume:
0.07
Capitalizzazione di mercato:
$4.22M
Reddito:
-
Utile/perdita netta:
$-6.91M
Rapporto P/E:
-0.5736
EPS:
-3.26
Flusso di cassa netto:
$-6.14M
1 W Prestazione:
-14.61%
1M Prestazione:
+6.86%
6M Prestazione:
-36.39%
1 anno Prestazione:
-50.54%
Intervallo 1D:
Value
$1.855
$1.9115
Intervallo di 1 settimana:
Value
$1.61
$2.34
Portata 52W:
Value
$1.15
$23.80

Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile

Name
Nome
Galmed Pharmaceuticals Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
6
Name
Cinguettio
@GalmedPharma
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
GLMD's Discussions on Twitter

Confronta GLMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GLMD
Galmed Pharmaceuticals Ltd
1.87 4.00M 0 -6.91M -6.14M -3.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-05-22 Downgrade B. Riley FBR Buy → Neutral
2020-02-04 Iniziato Craig Hallum Buy
2020-01-30 Ripresa Cantor Fitzgerald Overweight
2019-12-02 Iniziato Canaccord Genuity Buy
2018-12-12 Iniziato B. Riley FBR Buy
2018-08-02 Reiterato Maxim Group Buy
2018-07-13 Iniziato Stifel Buy
2018-07-12 Iniziato Cantor Fitzgerald Overweight
2018-06-12 Reiterato H.C. Wainwright Buy
2018-03-15 Aggiornamento Maxim Group Hold → Buy
2018-02-14 Downgrade Maxim Group Buy → Hold
2018-02-12 Reiterato H.C. Wainwright Buy
2017-11-15 Iniziato ROTH Capital Buy
2017-08-08 Reiterato H.C. Wainwright Buy
2017-07-31 Reiterato Maxim Group Buy
2016-08-01 Reiterato Maxim Group Buy
2016-07-06 Ripresa ROTH Capital Buy
2016-03-28 Ripresa H.C. Wainwright Buy
2015-06-23 Iniziato H.C. Wainwright Buy
2015-05-06 Iniziato Sun Trust Rbsn Humphrey Buy
Mostra tutto

Galmed Pharmaceuticals Ltd Borsa (GLMD) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about Galmed Pharmaceuticals Ltd. stockFree Stock Market Beginners Guide - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Galmed Pharmaceuticals Ltd. Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Galmed Pharmaceuticals Ltd. stock priceMassive stock growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Galmed Pharmaceuticals Ltd. a good long term investmentTurbocharged investment results - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

The Role of News and Events in Galmed Pharmaceuticals Ltd Inc. (GLMD) Price Performance - investchronicle.com

Jul 21, 2025
pulisher
Jul 20, 2025

Why India’s Pharmaceutical Stocks Are on the Rise High Accuracy Trade SignalsRapid market gains - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

Solara Active Pharma Sciences Limited (SOLARAPP)’s Trend in 2025Free Stock Market Forecast Reports - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

PLAB Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Galmed Pharmaceuticals Ltd. stock price move sharplyFree Insider Trading Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Galmed Pharmaceuticals Ltd. stock attracts strong analyst attentionSafe and Scalable Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Galmed Pharmaceuticals Ltd. stock performs during market volatilitySteady Profit Stock Forecasts - Newser

Jul 15, 2025
pulisher
Jun 03, 2025

Galmed Pharmaceuticals Ltd. to Host Earnings Call - ACCESS Newswire

Jun 03, 2025
pulisher
May 27, 2025

Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond Nash - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Galmed Pharmaceuticals Unveils Biomarker Signature for Aramchol, Expanding Market Potential - TipRanks

May 27, 2025
pulisher
May 27, 2025

Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond NASH - Longview News-Journal

May 27, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Galmed Pharmaceuticals (NASDAQ:GLMD) to Sell - Defense World

May 24, 2025
pulisher
May 23, 2025

Galmed Pharmaceuticals: Q1 Earnings Snapshot - New Haven Register

May 23, 2025
pulisher
May 22, 2025

Galmed Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Galmed Pharmaceuticals Reports Q1 2025 Financial Results and Advances in Oncology - TipRanks

May 22, 2025
pulisher
May 22, 2025

Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 22, 2025
pulisher
May 15, 2025

Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated at StockNews.com - Defense World

May 15, 2025
pulisher
May 14, 2025

Galmed Pharmaceuticals Unveils Promising Aramchol Results in PSC Models - TipRanks

May 14, 2025
pulisher
May 14, 2025

Galmed (GLMD) Announces Promising Pre-Clinical Results for Aramc - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Galmed (GLMD) Announces Promising Pre-Clinical Results for Aramchol in Treating PSC | GLMD Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in PSC Models - PR Newswire

May 13, 2025

Galmed Pharmaceuticals Ltd Azioni (GLMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):